医学
阿替唑单抗
免疫疗法
肿瘤科
化疗
肺癌
人口
内科学
索引(排版)
中性粒细胞与淋巴细胞比率
免疫学
淋巴细胞
癌症
无容量
环境卫生
万维网
计算机科学
作者
Pablo Cruz,B. Riesco Montes,L. Fernández Franco,Sandra Falagán,L.E. Chara,S. Simon Alonso,Oliver Higuera,S. Cerezo,L. Gutierrez-Sainz,J. Villamayor,R. Galan Moral,José Carlos Villa,R. Álvarez Cabellos,Alexis Rodríguez,R. Lopez Bajo,José Portela,María Concepción Serrano,José Ramón Muñoz‐Rodríguez
标识
DOI:10.1016/j.jtho.2023.09.1324
摘要
The neutrophil-lymphocyte ratio (Neutrophils/leukocytes-neutrophils) (NLR) and the LDH levels have been correlated in multiple studies with the response to immunotherapy in different tumors. Based on these two variables, the LIPI index was developed and was validated in non-small cell lung cancer (NSCLC) as a predictor of response to immunotherapy.Our study proposes the validation of LIPI index and NLR in SLCL, treated with first line (1L) with atezolizumab plus chemotherapy in our population.
科研通智能强力驱动
Strongly Powered by AbleSci AI